AVAXIA BIOLOGICS INC has a total of 37 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are PBL BIOMEDICAL LAB, TUGAI SEJJAKU KK and MODIGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | China | 2 | |
#7 | Brazil | 1 | |
#8 | Hong Kong | 1 | |
#9 | Hungary | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | New Zealand | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fox Barbara S | 35 |
#2 | Stafford Douglas C | 12 |
#3 | Bostwick Eileen F | 10 |
#4 | Quesenberry Michael S | 10 |
#5 | Schlehuber Lisa D | 6 |
#6 | Tracey Daniel E | 6 |
#7 | Daniel E Tracey | 1 |
#8 | Michael S Quesenberry | 1 |
#9 | Eileen F Bostwick | 1 |
#10 | Lisa D Schlehuber | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013245509A1 | Antibody therapeutics with local activity in the digestive tract | |
US2013337018A1 | Compositions comprising TNF-specific antibodies for oral delivery | |
CN103917555A | Bovine polyclonal antibody specific for human tnf | |
EP2694539A1 | Polyclonal antibody compositions | |
CN102596248A | Antibody therapeutics with local activity in the digestive tract | |
WO2009046168A1 | Antibody therapy for use in the digestive tract | |
WO2009020748A2 | Antibody therapy for modulating function of intestinal receptors | |
WO2007056301A2 | Antibody therapy for treatment of diseases associated with gluten intolerance |